Gsa Capital Partners LLP Molecular Templates, Inc. Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.81 - $3.43 $117,598 - $497,977	-145,183 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$2.27 - $4.13 $331 - $602	-146 Reduced 0.1%	145,183 $501,000
Q4 2021 Feb 14, 2022	BUY	$3.37 - $6.87 $358,928 - $731,703	106,507 Added 274.35%	145,329 $570,000
Q3 2021 Nov 12, 2021	BUY	$5.78 - $7.86 $1,312 - $1,784	227 Added 0.59%	38,822 $260,000
Q2 2021 Aug 05, 2021	BUY	$7.82 - $12.44 $301,812 - $480,121	38,595 New	38,595 $302,000
Q1 2021 May 10, 2021	SELL	$9.33 - $14.05 $353,989 - $533,071	-37,941 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$8.48 - $12.23 $223,456 - $322,272	26,351 Added 227.36%	37,941 $356,000
Q3 2020 Nov 06, 2020	BUY	$9.99 - $14.41 $115,784 - $167,011	11,590 New	11,590 $127,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.